尽管Russell Investments重申了2025年的预期,但由于收益低于预期,它出售了大部分Synopsys股票. Russell Investments sold most of its Synopsys shares as earnings missed expectations, despite reaffirming 2025 guidance.

罗素投资公司在第二季度出售了993股Synopsys (SNPS),将其股权减少到约122,458股,价值62.7亿美元. Russell Investments sold 993 shares of Synopsys (SNPS) in Q2, reducing its stake to about 122,458 shares worth $62.7 million. 该公司报告,Q2收入为每股2.30美元,缺失估计数为1.45美元,收入为17.4亿美元,略低于预期。 The company reported Q2 earnings of $2.30 per share, missing estimates by $1.45, and revenue of $1.74 billion, slightly below expectations. 尽管收入同比增长了14%,但Synopsys重申了其2025年全年预期. Despite a 14% year-over-year revenue increase, Synopsys reaffirmed its 2025 full-year guidance. 库存关闭409.68美元,分析师发布各种评级,导致达成共识的“等待”和平均价格目标为556.33美元。 The stock closed at $409.68, with analysts issuing a mix of ratings leading to a consensus "Hold" and an average price target of $556.33. 内幕销售在90天内共计30 894股,使内幕所有权减少到0.62%。 Insider sales totaled 30,894 shares in 90 days, reducing insider ownership to 0.62%.